Market Place
Sourcing Support
ILiAD and hVIVO Sign LOI for BPZE1 Phase 3 Pertussis Vaccine Trial
27 Jan 2025 //
BUSINESSWIRE
CRO hVIVO reels in £16.8M clinical trial deal for RSV drug
13 Dec 2023 //
FIERCE BIOTECH
hVIVO raises 2023 revenue view on demand for respiratory therapy testings
12 Sep 2023 //
REUTERS
CRO hVIVO inks deal to test RSV drug in human challenge trial
08 Feb 2023 //
FIERCE BIOTECH
Open Orphan signs £10.4 million contract with global pharma client
23 Aug 2022 //
PHARMAFILE
Open Orphan to commence influenza human challenge study
05 Aug 2022 //
PHARMA TIMES
Vaxart Announces Agreement with hVIVO to Develop Omicron Challenge Model
30 Jun 2022 //
GLOBENEWSWIRE
Open Orphan lands £7.3mln influenza human challenge study
19 May 2022 //
PHARMAFILE
Open Orphan subsidiary wins $13.4m contract with US biotech company
09 Dec 2021 //
IRISHTIMES
Open Orphan to conduct first-ever COVID-19 human challenge trial
22 Oct 2021 //
PHARMAFILE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.